Hualan Biological Engineering Inc
SZSE:002007
Relative Value
The Relative Value of one Hualan Biological Engineering Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 20.07 CNY, Hualan Biological Engineering Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Hualan Biological Engineering Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Hualan Biological Engineering Inc
SZSE:002007
|
36.6B CNY | 7 | 26.3 | 18.8 | 18.8 | ||
US |
Abbvie Inc
NYSE:ABBV
|
291B USD | 5.4 | 49 | 13.7 | 21.1 | ||
US |
Amgen Inc
NASDAQ:AMGN
|
167.8B USD | 5.7 | 44.7 | 18.8 | 31 | ||
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.5B USD | 11.3 | 28.8 | 24.1 | 25.2 | ||
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.7B USD | 8.3 | 28.1 | 22.7 | 25.2 | ||
AU |
CSL Ltd
ASX:CSL
|
134.3B AUD | 6.3 | 36.4 | 22 | 27.2 | ||
US |
Gilead Sciences Inc
NASDAQ:GILD
|
84.7B USD | 3.1 | 174.7 | 8.8 | 11.6 | ||
US |
Moderna Inc
NASDAQ:MRNA
|
54B USD | 10.5 | -9.1 | -10.1 | -9 | ||
US |
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | ||
US |
Biogen Inc
NASDAQ:BIIB
|
33.7B USD | 3.5 | 28.9 | 14.7 | 18.4 | ||
KR |
Celltrion Inc
KRX:068270
|
38.7T KRW | 17.8 | 72.3 | 44.3 | 61 |